PCilia Tracker
Commercial- Indications
- Prostate cancer detection
Company intelligence / Profile preview
New Life Medicine Technology
Hong Kong, Hong Kongnlmedtech.com.hk ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
New Life Medicine Technology develops frontier technologies for early cancer diagnosis and aims to provide low-cost, effective medical products that improve the efficiency and accuracy of clinical decision-making. The company is based in Hong Kong Science Park and focuses primarily on research and innovation for healthcare applications.
- Therapeutic areas
- Oncology
- Modalities
- DeviceSmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on New Life Medicine Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New Life Medicine Technology.